Redwood City police used a drone to arrest a man suspected of dealing drugs in the area of the Downtown Library on Tuesday evening.
From
To
Featured
South San Francisco officially designated April 7 as “Genentech Day” to commemorate the biotechnology giant’s 50th anniversary in the city.
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression. The agency announced the move Friday, following an executive order by President Donald Trump calling for the agency to speed up access to the mind-altering drugs. The move reflects growing popular support for the psychedelics among Trump's supporters, including combat veterans and followers of the Make America Healthy Again movement. The FDA also greenlighted initial testing of a drug related to ibogaine, a potent psychedelic linked to dangerous heart rhythms.
The San Mateo County Board of Supervisors voted unanimously to ban the sale of kratom products, which has been described as “gas station heroi…
The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases. The pathway laid out Monday is aimed to approving one-of-a-kind therapies, including those using emerging gene-editing technology. It's a shift long sought by patients, advocates and researchers focused on rare diseases, which often do not fit within the pharmaceutical industry's business model. For many rare diseases, drug companies have had little financial incentive to develop new treatments. The FDA proposal, if finalized, would codify a path for drugmakers and researchers to study and commercialize treatments without conducting large, expensive clinical trials.
San Mateo County announced the launch of a program this week to place emergency overdose medication in publicly accessible boxes around the county.
The Trump administration is set to launch TrumpRx, a website to help patients buy prescription drugs directly from manufacturers at discounted rates. White House press secretary Karoline Leavitt announced Thursday's expected unveiling in a social media post. The website is not a purchasing platform but directs users to drugmakers' own sites. President Trump first mentioned TrumpRx in September, highlighting deals with pharmaceutical companies to lower drug prices. The website's release faced delays, but it now showcases efforts to reduce costs through agreements with major companies like Pfizer and AstraZeneca. However, the actual savings for consumers remain unclear.
A Honolulu man charged with felony possession and transportation of narcotics, including fentanyl and methamphetamine, was hit with another se…
